Viral infections cause an enormous burden to health systems and the economy. Furthermore, emerging viruses, including H5N1 avian influenza, represent a pandemic threat. Although effective vaccines exist to protect against seasonal influenza, no vaccines are available against the recent H7N9 avian influenza strains. Some antiviral drugs might be available, but treatment is generally supportive and there is a pending risk of virus resistance.
New strategies for immune-mediated, anti-viral drugs and vaccine development have emerged in recent years. Viral infections and vaccine safety represent a prominent research field within Triskelion and we offer tailor-made viral infection models, including supportive in vitro analysis that specifically addresses your needs.